Acumen Pharmaceuticals (ABOS)
(Delayed Data from NSDQ)
$3.48 USD
+0.23 (7.08%)
Updated May 2, 2024 04:00 PM ET
After-Market: $3.47 -0.01 (-0.29%) 6:38 PM ET
2-Buy of 5 2
B Value F Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Acumen Pharmaceuticals (ABOS) reported earnings of -$0.29 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ABOS's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 17.86%.
Earnings History
Price & Consensus
Zacks News for ABOS
Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock?
ABOS: What are Zacks experts saying now?
Zacks Private Portfolio Services